18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study

20250 citationsJournal Articlegold Open Access

Authors

M. Chanchou · Université Clermont Auvergne

Marie‐Ange Mouret‐Reynier · Centre Jean Perrin

Ioana Molnar · Centre Jean Perrin

Emmanuel Deshayes · Inserm

Véronique D’Hondt · Inserm

K. Bourahla · Hôpital Civil, Strasbourg

Thierry Petit ·

Abstract

<sup>18</sup>F-FDG PET-CT before and after the first cycle of neoadjuvant treatment does not appear to be an effective tool to predict pCR in patients with HER2+ BC.

Topics & Keywords

Medical Imaging Techniques and Applications HER2/EGFR in Cancer Research Radiomics and Machine Learning in Medical Imaging

Publication Details

Published in: Breast Cancer Research

Volume 28, Issue 1, pp. 2-2

DOI: 10.1186/s13058-025-02156-w

Field-Weighted Citation Impact: 0.00

Command Palette

18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study

Authors

Abstract

Topics & Keywords

Publication Details